CP
TMDX icon

Castleview Partners’s Transmedics TMDX Stock Holding History

Castleview Partners’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,335
Closed -$247K – 997
2024
Q1 		$247K Buy
+3,335
New +$275K 0.14% 161

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Castleview Partners's TMDX Position: Q2 2024 in Review

Castleview Partners sold out of Transmedics (TMDX) in Q2 2024, closing a stake of 3,335 shares — an estimated $247K sold.

Castleview Partners first reported a position in TMDX in Q1 2024 and held it in 1 quarter. The position peaked at $247K in Q1 2024. 340 funds tracked by Wall St. Rank hold TMDX as of Q2 2024.

  • Castleview Partners reported no remaining Transmedics position as of Q2 2024 after selling out during the quarter.
  • Castleview Partners sold 3,335 Transmedics shares in Q2 2024, an estimated $247K.
  • Castleview Partners first reported a position in Transmedics in Q1 2024 and held it in 1 quarter.
  • Castleview Partners's Transmedics position peaked at $247K in Q1 2024.
  • 340 funds tracked by Wall St. Rank held Transmedics as of Q2 2024.

Based on Castleview Partners's 13F filing for Q2 2024, filed 31 Jul 2024.